FDA Urges Greater Compliance With Ad Submission Regulations
Executive Summary
Industry needs to improve compliance with regulations requiring the submission of promotional materials to the agency, CDER Division of Drug Marketing, Advertising & Communications Regulatory Counsel Kristin Davis said
You may also be interested in...
DTC Restrictions Ahead: Risk Management Plans, “Drug Watch” Are Vehicles
FDA will manifest its tougher stance on DTC advertising in requirements for more extensive risk management plans, Hogan & Hartson Partner Robert Brady predicted at a Regulatory Affairs Professionals Society conference in Chicago
Pfizer Supports Stronger FDA Oversight Of DTC Promotions
Pfizer supports stronger "external oversight" of direct-to-consumer advertising, CEO Hank McKinnell says in his recently released book A Call To Action: Taking Back Healthcare for Future Generations.
FDA’s Crawford Praises DTC Advertising; PhRMA’s Tauzin Pushes For Change
FDA Acting Commissioner Lester Crawford is highlighting the benefits of direct-to-consumer advertising rather than the need for agency regulation of the practice